Amy Jacob

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Chris Cannon, MD, Brigham & Women's Hospital, discussed the latest changes with the dyslipidemia guidelines.

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Michael Lincoff, MD, Cleveland Clinic explained results from ACCELERATE trial involving patients with high risk vascular disease who received evacetrapib on top of standard care.

Renato Delascio Lopes, MD, Duke University Medical Center, discussed at the European Society of Cardiology Congress 2016 (ESC), the progress of anticoagulant therapies for patients.

Victor Sandor, MD, Array BioPharma, shared results from ARRY 797 study at the European Society of Cardiology Congress 2016.

At the European Society of Cardiology Congress 2016 (ESC), Sigrun Halvorsen, MD, Oslo University discussed the results of her study which analyzed the bleeding rates among NVAF patients who were prescribed anticoagulants.

Christopher Granger, MD, professor of medicine, director of the Critical Care Unit at the Duke University Medical Center discussed that the European Society of Cardiology (ESC) has grown to be one of the best forums to discuss best practices of cardiovascular care.

Experts at the European Society of Cardiology Congress 2016 (ESC) expressed varied opinions on the DANISH trial. Researchers presented that implantable cardioverter-defibrillators (ICDs) do not work for all heart patients.

Christopher Granger, MD, Duke University Medical Center also spoke at the European Society of Cardiology COngress 2016 about the issues surrounding patients' tolerability of anticoagulants and other drugs.

Sonal Bhatia, MD, Vice President, Global Eliquis Medical Lead, Pfizer, highlighted the significance of the consistency in data over the last five years, in relation to the five-year-anniversary of her team's Aristotle study at the European Society of Cardiology 2016 (ESC).

Emerging more frequently as part of the total evidence generated with Eliquis, real-world data allows researchers to work with larger populations to show specific reductions in major bleeding and stroke, as well.

Poushali Mukherjea, PhD, Executive Director, Global Medical Affairs, Bristol-Myers Squibb, noted some key takeaways from her team's 19 abstracts slated to be presented at the European Society of Cardiology Congress 2016 (ESC).

To help physicians effectively manage septic perianal Crohn’s disease (CD), Penn State College of Medicine researchers published a medical and surgical care plan based on a decade’s worth of analyses and patient outcomes.

Calcium supplements may seem to be a safe and effective method to manage osteoporosis, but regular consumption of these pills could increase the risk of dementia in women, specifically those who have experienced cerebrovascular diseases or poor blood flow to the brain, or have suffered a stroke.

Ginger ale has long been considered a non-medicinal option for soothing upset stomachs. Didier Merlin, MD, and colleagues from the Atlanta VA medical Center and Institute for Biomedical Sciences at Georgia State University, have taken this concept a step further, exploring the use of edible ginger-derived nanoparticles (GDNPs) to treat inflammatory bowel disease.

While it has been known for some time that psoriasis patients are at increased risk of developing cardiovascular disease and other comorbidities, new research has shown that these patients also have a higher risk of developing aortic aneurysms.

Many psoriasis patients wish they were better informed of the significant impact their skin condition would have on their physical and mental health, according to results from Psoriasis in America 2016, a Health Union national survey.

Children suffering from generalized pustular psoriasis (GPP), who haven’t been responding favorably to traditional therapies, can potentially benefit from biologics treatment.

Patients afflicted with severe psoriasis may be at higher risk for chronic pancreatitis (CP).

Taking the dual approach in biologic and phototherapy treatments appears to be a more beneficial clinical treatment method for patients suffering from moderate-to-severe psoriasis.

MD Magazine spoke with world-renowned soccer star, Brandi Chastain, who recently partnered with AbbVie on a new advocacy campaign, My IBD Game Plan, in the wake of her son’s Crohn’s disease diagnosis. Millie Long, MD, MPH, shared the clinical landscape and management methods for the condition.

Enjoying a nice steak dinner may actually take a toll on the kidneys, increasing people’s risk for kidney disease, or failure.

While the influenza vaccine has endured its fair share of controversy, new research shed light on one of the flu shot’s added benefits: diabetes patients who get the vaccine may not suffer as many cardiovascular or respiratory problems.

The gut microbiome has previously been considered a therapeutic target for the immune system, and new research suggests the microbiome’s composition can hold the key to managing psoriasis.

Successfully measuring the eye pressure of people with obstructive sleep apnea (OSA) indicated to scientists for the first time a relationship between sleep apnea and glaucoma.

Dietary oily fish content and other omega 3 fatty acids can benefit patients suffering from bowel (colorectal) cancer, and even lower their risk of death.

A new CDC study revealed that gonorrhea is on the verge of developing resistance to the most commonly recommended antibiotic treatments – oral azithromycin and single-injection ceftriaxone.

In addition to battling gastrointestinal conditions, patients suffering from ulcerative colitis (UC) also often have to deal with poor oral health.

The FDA has approved UltraShape Power (Syneron Medical Ltd) for non-invasive reduction of abdominal circumference through fat cell destruction.

The Zika virus can be spread by sexual contact with an infected woman, the US Centers for Disease Control and Prevention announced today. The finding came after New York City DOH officials reported their first case.

Award-winning chef Elizabeth Falkner and board-certified dermatologist Doris Day spoke with MD Magazine about their collaborative efforts on a new atopic dermatitis campaign, ‘Understand AD.’